Tvardi Therapeutics, Inc. (TVRD)
NASDAQ·Healthcare·Biotechnology
$2.57
-2.28%
Mkt Cap $37.34M
Analyst Ratings
No recent rating data.
Price Target (5 analysts)
$3.00
Range $3.00 – $3.00
Implied Upside
+16.7%
Consensus $3.00 vs current $2.57
NASDAQ·Healthcare·Biotechnology
$2.57
-2.28%
Mkt Cap $37.34M
No recent rating data.
Price Target (5 analysts)
$3.00
Range $3.00 – $3.00
+16.7%
Consensus $3.00 vs current $2.57